Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the Nasdaq Global Market today under the symbol “CADL”. The firm’s initial public offering is looking to raise US$72.0 million and is expected to close on July 29, 2021.

The offering will be conducted through the issuance of 9,000,000 common shares selling at US$8.00 per share. This is an adjustment from the company’s original plan to issue 6.1 million shares with share price expectations between US$13.00 and US$15.00.

The company granted a 30-day over-allotment option to purchase additional 1,350,000 common shares at the same IPO price, potentially bringing proceeds up to US$82.8 million. Jefferies, Credit Suisse, BMO Capital Markets, and UBS Investment Bank are all acting as joint bookrunners for the said offering.

The Massachusetts-based biotech firm is in the business of developing novel oncolytic viral immunotherapies to treat patients with cancer, inducing “immunogenic cell death in cancer cells at the site of injection”. Currently, Candel Therapeutics has immunotherapy platforms in its portfolio –the lead adenovirus platform product candidate CAN-2409 and the lead HSV platform product candidate CAN-3310.


Information for this briefing was found via Sedar and Candel Therapeutics. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Energy SPAC Kimbell Tiger Acquisition Prices US$200 Million IPO

Blank check company Kimbell Tiger Acquisition Corporation (NYSE: TGR.U) went public today on the New...

Friday, February 4, 2022, 02:28:00 PM

Connectivity Firm Credo Prices US$200 Million Nasdaq IPO

Connectivity solutions provider Credo Technology Group (Nasdaq: CRDO) started trading on the Nasdaq Global Select...

Thursday, January 27, 2022, 02:19:00 PM

Online Car Retailer Vroom Files for IPO

Rumours have started swirling that online used-car seller Vroom has filed for an initial public...

Monday, May 11, 2020, 06:17:23 PM

SPAC Welsbach Technology Metals Acquisition Prices US$75 Million IPO

Special purpose acquisition company Welsbach Technology Metals Acquisition Corp. (Nasdaq: WTMAU) started trading publicly on...

Wednesday, December 29, 2021, 02:18:00 PM

Dating App Grindr Swipes Right To Potential US$2.1 Billion SPAC Merger

LGBTQ+ dating app Grindr announced on Monday the potential business combination agreement with special purpose...

Tuesday, May 10, 2022, 02:25:00 PM